The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tackle Tricky Lung Complications in Connective Tissue Disease

Tackle Tricky Lung Complications in Connective Tissue Disease

February 15, 2013 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

WASHINGTON, D.C.–Interstitial lung disease (ILD) is associated with a number of rheumatic diseases, and patients may be referred by pulmonologists to rheumatologists for management. Patients with one of these conditions, especially when associated with connective tissue diseases, often have poor prognoses. Diagnosis can be challenging, and there are still few effective therapies for many of these conditions.

You Might Also Like
  • When Interstitial Lung Disease and Connective Tissue Disorder Intersect in Rheumatology Patients
  • Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease
  • Summit on Connective Tissue Disease-Associated ILD Fosters Interdisciplinary Dialogue
Also By This Author
  • ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

A panel of experts on connective tissue–associated ILD spoke at a session titled, “Connective Tissue Disease–Associated Interstitial Lung Disease,” at the 2012 ACR/ARHP Annual Meeting, held here November 9–14. [Editor’s Note: This session was recorded and is available via ACR SessionSelect.] They offered some insight on diagnosing and treating these patients, as well as a glimpse into areas of research that may be promising.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ILD is a group of conditions associated with many connective-tissue diseases, said Aryeh Fischer, MD, acting chief of the division of rheumatology at National Jewish Health in Denver. These conditions typically are marked by interstitial inflammation and/or fibrosis of the lungs. Symptoms are not always clear, but imaging, histopathologic, and function tests may provide the best clues for diagnosis, he said.

Serious and More Mild ILDs

One of the most serious connective tissue–associated ILDs is usual interstitial pneumonia (UIP), an idiopathic condition marked by a honeycombing pattern seen on radiographs and fibrosis, Dr. Fischer said. UIP is most commonly seen in rheumatoid arthritis (RA) and is also commonly seen in scleroderma and systemic sclerosis. It has the worst prognosis in this classification, Dr. Fischer noted.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Another commonly seen ILD in rheumatic diseases is nonspecific interstitial pneumonia, a condition with a better prognosis than UIP. Prognosis for survival can depend on factors like the patient’s age, smoking status, and familial history, Dr. Fischer noted. Patients with RA may also develop bronchiolitis obliterans organizing pneumonia, an inflammation of the bronchioles with a comparatively good prognosis for recovery. Other conditions that may be seen in rheumatic disease patients include lymphocytic interstitial pneumonia and, more rarely, severe acute interstitial pneumonia.

Where ILD Is Most Common

ILD is most commonly found in systemic sclerosis at a prevalence rate of 25% to 90%, Dr. Fischer said. It is also found less frequently in polymyositis and dermatomyositis, RA, Sjögren’s syndrome, and systemic lupus erythematosus. If rheumatologists are treating patients with known connective tissue disease, they should take steps to determine if possible ILD is connective tissue disease¬ associated, Dr. Fischer said. Recognition of the exact disease would affect treatment decisions and the prognosis for these patients. “It’s important for the patients’ outcome to see where they fit,” he said.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Scleroderma Tagged With: connective tissue disease, Interstitial Lung Disease, Systemic sclerosis

You Might Also Like:
  • When Interstitial Lung Disease and Connective Tissue Disorder Intersect in Rheumatology Patients
  • Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease
  • Summit on Connective Tissue Disease-Associated ILD Fosters Interdisciplinary Dialogue
  • The ACR’s State-of-the-Art Clinical Symposium: Patients with Scleroderma, Lung Disease May Benefit from Aggressive Therapy

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.